Weiqun Peng

Has grant

Professor

George Washington University
Country flagUnited States

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Weiqun Peng is a Professor at The George Washington University in the United States. His research primarily focuses on T cell development and differentiation, exploring the regulatory mechanisms that govern CD8 + T cell identity and function. Recent publications include studies on the roles of Hdac1, Tcf1, and CTCF in shaping genomic architecture and metabolic programming during immune responses. Additionally, he investigates the long-term changes in memory T cell functionality following sepsis.

Recent Grants

Grant: Close

Ezh2 regulates follicular helper T cell differentiation

Open Date: 2018-09-24

Close Date: 2023-08-31

Grant: Open

CTCF in CD8 T cell homeostasis and anti-viral/tumor immunity

Open Date: 2016-06-01

Close Date: 2027-07-31

Grant: Close

Characterization of Regulated Intron Retention in T Cell Activation

Open Date: 2014-07-01

Close Date: 2017-06-30

Articles (11)

Year:

2025

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (8)

Qing Chen

Boston University

UNITED STATES
View details

Vladimir P. Badovinac

-

UNITED STATES
View details

Young-Kwon Park

National Institutes of Health

UNITED STATES
View details

Patrick McGonagill

Clinical Assistant Professor

University of Iowa Healthcare

UNITED STATES
View details

Chongzhi Zang

Associate Professor

University of Virginia

UNITED STATES
View details

Weidong Wang

National Institute on Aging Intramural Research Program

UNITED STATES
View details

Jon Houtman

Associate Professor

Iowa State University

UNITED STATES
View details

Hai-Hui Xue

-

UNITED STATES
View details
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.